{"id":"https://openalex.org/W2109747317","doi":"https://doi.org/10.1124/mol.54.6.1046","title":"Protective Effects of the Antiparkinsonian Drugs Talipexole and Pramipexole against 1-Methyl-4-phenylpyridinium-Induced Apoptotic Death in Human Neuroblastoma SH-SY5Y Cells","display_name":"Protective Effects of the Antiparkinsonian Drugs Talipexole and Pramipexole against 1-Methyl-4-phenylpyridinium-Induced Apoptotic Death in Human Neuroblastoma SH-SY5Y Cells","alternate_titles":[],"publication_year":1998,"publication_date":"1998-12-01","ids":{"openalex":"https://openalex.org/W2109747317","doi":"https://doi.org/10.1124/mol.54.6.1046","mag":"2109747317","pmid":"https://pubmed.ncbi.nlm.nih.gov/9855633"},"language":"en","primary_location":{"id":"doi:10.1124/mol.54.6.1046","doi":"https://doi.org/10.1124/mol.54.6.1046","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.54.6.1046","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2109747317"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101577336","display_name":"Yoshihisa Kitamura","orcid":"https://orcid.org/0000-0002-3652-3722","observed_orcids":["https://orcid.org/0000-0002-3652-3722"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshihisa Kitamura","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Department of Neurobiology Kyoto Pharmaceutical University Kyoto 607-8412 Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Department of Neurobiology Kyoto Pharmaceutical University Kyoto 607-8412 Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tadashi Kosaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tadashi Kosaka","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Kyoto Pharmaceutical University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University, Kyoto, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083849851","display_name":"Jun\u2010ichi Kakimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jun-Ichi Kakimura","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Kyoto Pharmaceutical University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University, Kyoto, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091308349","display_name":"Yasuji Matsuoka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuji Matsuoka","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Kyoto Pharmaceutical University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University, Kyoto, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108487661","display_name":"Yasuko Kohno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuko Kohno","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Kyoto Pharmaceutical University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University, Kyoto, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103267522","display_name":"Yasuyuki Nomura","orcid":"https://orcid.org/0000-0003-4433-3598","observed_orcids":["https://orcid.org/0000-0003-4433-3598"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yasuyuki Nomura","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Kyoto Pharmaceutical University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University, Kyoto, Japan","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024903237","display_name":"Takashi Taniguchi","orcid":"https://orcid.org/0000-0003-0017-7669","observed_orcids":["https://orcid.org/0000-0003-0017-7669"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]},{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takashi Taniguchi","raw_affiliation_strings":["1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","Kyoto Pharmaceutical University, Kyoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Neurobiology (Y.Ki., T.K., J.K., Y.M., T.T.), Kyoto Pharmaceutical University, Kyoto 607-8412, Japan, \n2Product Management Department (Y.Ko.), Marketing Division, Nippon Boehringer Ingelheim, Hyogo 666-0193, Japan, and \n3Department of Pharmacology (Y.N.), Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan","institution_ids":["https://openalex.org/I205349734","https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University, Kyoto, Japan","institution_ids":["https://openalex.org/I25998863"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":5.6258,"has_fulltext":false,"cited_by_count":193,"citation_normalized_percentile":{"value":0.96287025,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"54","issue":"6","first_page":"1046","last_page":"1054"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/talipexole","display_name":"talipexole","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pramipexole","display_name":"pramipexole","score":1.0},{"id":"https://openalex.org/keywords/bromocriptine","display_name":"bromocriptine","score":0.8970000147819519},{"id":"https://openalex.org/keywords/mpp","display_name":"MPP+","score":0.9649999737739563},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.734000027179718},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8429999947547913},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.878000020980835},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.9639999866485596},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.8709999918937683},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9649999737739563},{"id":"https://openalex.org/keywords/parp-cleavage","display_name":"PARP cleavage","score":0.9769999980926514},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8429999947547913},{"id":"https://openalex.org/keywords/dopamine-agonists","display_name":"dopamine agonists","score":0.6840000152587891},{"id":"https://openalex.org/keywords/sh-sy5y-cells","display_name":"SH-SY5Y cells","score":0.8169999718666077},{"id":"https://openalex.org/keywords/calphostin-c","display_name":"calphostin C","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dibutyryl-camp","display_name":"dibutyryl cyclic AMP","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C2779989193","wikidata":"https://www.wikidata.org/wiki/Q421304","display_name":"Pramipexole","level":4,"score":0.8500115871429443},{"id":"https://openalex.org/C2779083432","wikidata":"https://www.wikidata.org/wiki/Q7390126","display_name":"SH-SY5Y","level":4,"score":0.7783467173576355},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7339979410171509},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.7109413743019104},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7093619108200073},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.5751203894615173},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.5740119218826294},{"id":"https://openalex.org/C43759708","wikidata":"https://www.wikidata.org/wiki/Q3749256","display_name":"DNA fragmentation","level":4,"score":0.49011287093162537},{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.4723537862300873},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4392988681793213},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.42102542519569397},{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.29874688386917114},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.20195460319519043},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18400877714157104},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16555184125900269},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11072254180908203},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07489249110221863},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07454723119735718},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.062118202447891235},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.06112170219421387},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077487","descriptor_name":"Pramipexole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001971","descriptor_name":"Bromocriptine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003994","descriptor_name":"Bucladesine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015655","descriptor_name":"1-Methyl-4-phenylpyridinium","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018491","descriptor_name":"Dopamine Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D020169","descriptor_name":"Caspases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053148","descriptor_name":"Caspase 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1124/mol.54.6.1046","doi":"https://doi.org/10.1124/mol.54.6.1046","is_oa":false,"landing_page_url":"https://doi.org/10.1124/mol.54.6.1046","pdf_url":null,"source":{"id":"https://openalex.org/S62949411","display_name":"Molecular Pharmacology","issn_l":"0026-895X","issn":["0026-895X","1521-0111"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmacology","raw_type":"journal-article"},{"id":"pmid:9855633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9855633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.982.4505","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.982.4505","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://molpharm.aspetjournals.org/content/54/6/1046.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W48673182","https://openalex.org/W116796221","https://openalex.org/W1602098835","https://openalex.org/W1966539065","https://openalex.org/W1969800514","https://openalex.org/W1970095022","https://openalex.org/W1970792750","https://openalex.org/W1976468205","https://openalex.org/W1990056937","https://openalex.org/W1993614295","https://openalex.org/W1996180957","https://openalex.org/W1997208169","https://openalex.org/W1998938785","https://openalex.org/W2002056677","https://openalex.org/W2031538419","https://openalex.org/W2033126835","https://openalex.org/W2034783956","https://openalex.org/W2037132500","https://openalex.org/W2037473273","https://openalex.org/W2038400756","https://openalex.org/W2040558323","https://openalex.org/W2048149415","https://openalex.org/W2056365448","https://openalex.org/W2059718548","https://openalex.org/W2060454311","https://openalex.org/W2062251719","https://openalex.org/W2062291914","https://openalex.org/W2063960864","https://openalex.org/W2063985177","https://openalex.org/W2071417712","https://openalex.org/W2076009972","https://openalex.org/W2081145901","https://openalex.org/W2092553981","https://openalex.org/W2093095942","https://openalex.org/W2120428186","https://openalex.org/W2135248083","https://openalex.org/W2146320943","https://openalex.org/W2146889361","https://openalex.org/W2150710841","https://openalex.org/W2172072395","https://openalex.org/W4300882461"],"related_works":["https://openalex.org/W2068800657","https://openalex.org/W2076883355","https://openalex.org/W2110382075","https://openalex.org/W2052644383","https://openalex.org/W2605987548","https://openalex.org/W2038400756","https://openalex.org/W2074475472","https://openalex.org/W1964970715"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2109747317","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
